| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7291324 | BRAINTREE | Method of bowel cleansing |
Oct, 2022
(1 year, 6 months ago) | |
Halflytely is owned by Braintree.
Halflytely contains Bisacodyl; Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride.
Halflytely has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Halflytely are:
- US7291324
Halflytely was authorised for market use on 24 September, 2007.
Halflytely is available in for solution, tablet, delayed release;oral dosage forms.
Halflytely can be used as gastrointestinal lavage indicated for cleansing of the colon as a preparation for colonoscopy in adults.
The generics of Halflytely are possible to be released after 22 October, 2022.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Jul 16, 2013 |
Market Authorisation Date: 24 September, 2007
Treatment: Gastrointestinal lavage indicated for cleansing of the colon as a preparation for colonoscopy in adults
Dosage: FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL
HALFLYTELY family patents
